| 13:30-13:50 | Keynote |
A critical role for glassy states biomolecular condensates in nanoscale regulation of biology |
|
||||
| 13:50-14:10 | Keynote |
NPY Nanosystems for Boundarics in Tumor |
|
||||
| 14:10-14:25 | Invited |
Targeted responsive nanoparticles degrade BRD4 to reverse glioma resistance |
|
||||
| 14:25-14:40 | Invited |
Prodrug-Based Nanotheranostic Platform for Cancer Radiosensitization |
|
||||
| 14:40-14:50 | Oral Report |
Biomimetic nanomedicines with glycan modification for the enhanced treatment of pathogenic infections |
|
||||
| 14:50-15:00 | Oral Report |
Bioactive nanomaterials for cancer therapy, diabetes regulation and mRNA delivery |
|
||||
| 15:00-15:10 | Oral Report |
Submolecular-level dynamic engineering of ligand nanostructure for macrophage immunoregulation |
|
||||
| 15:10-15:20 | Oral Report |
Polymer-coated iron oxide-embedded lipid nanoparticles (PcIOeLNPs) for mRNA delivery and MRI identified accumulation |
|
||||
| 15:30-15:45 | Other |
Coffee Break |
|||||
| 15:45-16:05 | Keynote |
RNA Delivery for Treating Brain Disorders |
|
||||
| 16:05-16:25 | Keynote |
Transformative nanomedicine: from bench to clinic |
|
||||
| 16:25-16:45 | Keynote |
Application of Nanocarrier Surface Modification Strategies in the Development of Innovative Pharmaceutical Formulations |
|
||||
| 16:45-17:00 | Invited |
Application of biomedical materials in disease immunotherapy |
|
||||
| 17:00-17:15 | Invited |
Biodegradable hybrid systems for preventing postoperative tumor recurrence and metastasis |
|
||||
| 17:15-17:25 | Oral Report |
Dual strategy of Ca2+ influx and collagen denaturation to remodel the extracellular matrix and amplify sonopiezoelectric therapy |
|
||||
| 17:25-17:30 | Oral Report |
Bimetallic peroxide nanocomposites-driven redox dyshomeostasis to activate sequential cuproptosis and pyroptosis for amplified tumor immunotherapy |
|
||||